Case Report on a Patient with Steinert Disease Complicated by COVID-19.
Roberto ChalelaOswaldo Antonio Caguana VélezFlavio ZuccarinoKarys KhilziDiego A Rodríguez-ChiaradíaPublished in: Vascular health and risk management (2020)
SARS-CoV-2 infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with SARS-CoV-2 infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors.
Keyphrases
- pulmonary embolism
- case report
- end stage renal disease
- coronavirus disease
- emergency department
- risk factors
- sars cov
- chronic kidney disease
- newly diagnosed
- ejection fraction
- peritoneal dialysis
- respiratory syndrome coronavirus
- patient reported outcomes
- pulmonary hypertension
- inferior vena cava
- liver failure
- sleep quality
- physical activity
- coronary artery disease
- respiratory failure
- patient reported